Chemical derivatization of chitosan for plasmid DNA delivery: Present and future

Chitin, Chitosan, Oligosaccharides and Their Derivatives: Biological Activities and Applications

Volumn , Issue , 2010, Pages 69-79

  Lai, Wing Fu ^a   Lin, Marie Chia Mi ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952603143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/EBK1439816035     Document Type: Chapter

References (73)

1. Aiba, S. 1992. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans. International Journal of Biological Macromolecules 14: 225-228.
2. Bendiske, J., Caba, E., Brown, Q. B., and Bahr, B. A. 2002. Intracellular deposition, microtubule destabilization, and transport failure: An “early” pathogenic cascade leading to synaptic decline. Journal of Neuropathology and Experimental Neurology 61: 640-650.
3. Bernkop-Schnurch, A., Hornof, M., and Zoidl, T. 2003. Thiolated polymers—thiomers: Synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. International Journal of Pharmaceutics 260: 229-237.
4. Bernkop-Schnurch, A., Guggi, D., and Pinter, Y. 2004. Thiolated chitosans: Development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. Journal of Controlled Release 94: 177-186.
5. Betz, A. L., Yang, G. Y., and Davidson, B. L. 1995. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. Journal of Cerebral Blood Flow and Metabolism 15: 547-551.
6. Boussif, O., Lezoualc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 92: 7297-7301.
7. Bowman, K., Sarkar, R., Raut, S., and Leong, K. W. 2008. Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles. Journal of Controlled Release 132: 252-259.
8. Brissault, B., Kichler, A., Guis, C., Leborgne, C., Danos, O., and Cheradame, H. 2003. Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjugate Chemistry 14: 581-587.
9. Burzynski, S. R. 2003. Gene silencing—A new theory of aging. Medical Hypotheses 60: 578-583.
10. Chae, S. Y., Son, S., Lee, M., Jang, M. K., and Nah, J. W. 2005. Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. Journal of Controlled Release 109: 330-344.
11. Chan, P., Kurisawa, M., Chung, J. E., and Yang, Y. Y. 2007. Synthesis and characterization of chitosan-gpoly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials 28: 540-549.
12. Chao, M. V. 2003. Neurotrophins and their receptors: A convergence point for many signaling pathways. Nature Reviews Neuroscience 4: 299-309.
13. Chemin, I., Moradpour, D., Wieland, S., Offensperger, W. B., Walter, E., Behr, J. P., and Blum, H. E. 1998. Liver-directed gene transfer: A linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. Journal of Viral Hepatitis 5: 369-375.
14. Costantini, L. C., Jacoby, D. R., Wang, S., Fraefel, C., Breakefield, X. O., and Isacson, O. 1999. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Human Gene Therapy 10: 2481-2494.
15. da Silva, A. M., Payao, S. L., Borsatto, B., Bertolucci, P. H., and Smith, M. A. 2000. Quantitative evaluation of the rRNA in Alzheimer’s disease. Mechanisms of Ageing and Development 120: 57-64.
16. Davis, M. E. 2002. Non-viral gene delivery systems. Current Opinion in Biotechnology 13: 128-131.
17. Elnakat, H. and Ratnam, M. 2004. Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Advanced Drug Delivery Reviews 56: 1067-1084.
18. Fu, C., Hong, G., and Wang, F. 2007. Favorable effect of local VEGF gene injection on axonal regeneration in the rat sciatic nerve. Journal of Huazhong University of Science and Technology 27: 186-189.
19. Gao, X., Kim, K. S., and Liu, D. 2007. Nonviral gene delivery: What we know and what is next. The AAPS Journal 9: E92-E104.
20. Goula, D., Remy, J. S., Erbacher, P., Wasowicz, M., Levi, G., Abdallah, B., and Demeneix, B. A., 1998. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Therapy 5: 712-717.
21. Hall, T. C., Miller, A. K. H., and Corsellis, J. A. N. 1975. Variations in the human Purkinje cell population according to age and sex. Neuropathology and Applied Neurobiology 1: 267-292.
22. Hattori, Y. and Maitani, Y. 2005. Folate-linked lipid-based nanoparticle for targeted gene delivery. Current Drug Delivery 2: 243-252.
23. Heras, A., Rodriguez, N. M., Ramos, V. M., and Agullo, E. 2001. N-methylene phosphonic chitosan: A novel soluble derivative. Carbohydrate Polymers 44: 1-8.
24. Hipkiss, A. R. 2008. Energy metabolism, altered proteins, sirtuins and ageing: Converging mechanisms? Biogerontology 9: 49-55.
25. Hirano, S., Seino, H., Akiyam, Y., and Nonako, I. 1988. Biocompatibility of chitosan by oral and intravenous administration. Polymer Engineering and Science 59: 897-901.
26. Hu, F. Q., Zhao, M. D., Yuan, H., You, J., Du, Y. Z., and Zeng, S. 2006. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: Properties and in vitro transfection studies. International Journal of Pharmaceutics 315: 158-166.
27. Ikura, T. and Ogryzko, V. V. 2003. Chromatin dynamics and DNA repair. Frontiers in Bioscience 8: s149-s155.
28. Je, J. Y., Cho, Y. S., and Kim, S. K. 2006. Characterization of (aminoethyl)chitin/DNA nanoparticle for gene delivery. Biomacromolecules 7: 3448-3451.
29. Jiang, H. L., Kim, Y. K., Arote, R., Nah, J. W., Cho, M. H., Choi, Y. J., Akaike, T., and Cho, C. S. 2007a. Chitosan-graft-polyethylenimine as a gene carrier. Journal of Controlled Release 117: 273-280.
30. Jiang, H. L., Kwon, J. T., Kim, Y. K., Kim, E. M., Arote, R., Jeong, H. J., Nah, J. W., Choi, Y. J., Akaike, T., Cho, M. H., and Cho, C. S. 2007b. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene Therapy 14: 1389-1398.
31. Jiang, H. L., Xu, C. X., Kim, Y. K., Arote, R., Jere, D., Lim, H. T., Cho, M. H., and Cho, C. S. 2009. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 30:5844-5852.
32. Kai, E. and Ochiya, T. 2004. A method for oral DNA delivery with N-acetylated chitosan. Pharmaceutical Research 21: 838-843.
33. Kaneda, Y. 2005. Biological barriers to gene transfer. In Polymeric Gene Delivery: Principles and Applications, ed. M. M. Amiji, pp. 29-42. Boca Raton, FL: CRC Press LLC.
34. Kemble, F. 1967. Conduction in the normal adult median nerve. The different effect of aging in men and women. Electromyography 7: 275-289.
35. Kim, S. K. and Rajapakse, N. 2005. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydrate Polymers 62: 357-368.
36. Kim, Y. H., Gihm, S. H., Park, C. R., Lee, K. Y., Kim, T. W., Kwon, I. C., Chung, H., and Jeong, S. Y. 2001. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjugate Chemistry 12: 932-938.
37. Kindy, M., Yu, J., Miller, R., Roos, R., and Ghadge, O. 1996. Adenoviral vectors in ischemic injury. In Pharmacology of Cerebral Ischemia, ed. J. Krieglstein, pp. 525-535. Stuttgart, Germany: Medpharm.
38. Koda, M., Hashimoto, M., Murakami, M., Yoshinaga, K., Ikeda, O., Yamazaki, M., Koshizuka, S., Kamada, T., Moriya, H., Shirasawa, H., Sakao, S., and Ino, H. 2004. Adenovirus vector-mediated in vivo gene transfer of brain-derived neurotrophic factor (BDNF) promotes rubrospinal axonal regeneration and functional recovery after complete transection of the adult rat spinal cord. Journal of Neurotrauma 21: 329-337.
39. Koda, M., Kamada, T., Hashimoto, M., Murakami, M., Shirasawa, H., Sakao, S., Ino, H., Yoshinaga, K., Koshizuka, S., Moriya, H., and Yamazaki, M. 2007. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. European Spine Journal 16: 2206-2214.
40. Koping-Hoggard, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Varum, K. M., and Artursson, P. 2001. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Therapy 8: 1108-1121.
41. Kunath, K., von Harpe, A., Fischer, D., Petersen, H., Bickel, U., Voigt, K., and Kissel, T. 2003. Low-molecularweight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. Journal of Controlled Release 89: 113-125.
42. Lai, W. F. and Lin, M. C. M. 2009. Nucleic acid delivery with chitosan and its derivatives. Journal of Controlled Release 134: 158-168.
43. Lee, K. Y., Kwon, I. C., Kim, Y. H., Jo, W. H., and Jeong, S. Y. 1998. Preparation of chitosan self-aggregates as a gene delivery system. Journal of Controlled Release 51: 213-220.
44. Lee, H., Jeong, J. H., and Park, T. G. 2001. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. Journal of Controlled Release 76: 183-192.
45. Lee, D., Zhang, W., Shirley, S. A., Kong, X., Hellermann, G. R., Lockey, R. F., and Mohapatra, S. S. 2007. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharmaceutical Research 24: 157-167.
46. Loretz, B. and Bernkop-Schnurch, A. 2006. In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system. The AAPS Journal 8: E756-E764.
47. Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., and Fernandes, J. C. 2006. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27: 2060-2065.
48. Matherly, L. H. and Goldman, D. I. 2003. Membrane transport of folates. Vitamins and Hormones 66: 403-456.
49. McLaughlin, J., Roozendaal, B., Dumas, T., Gupta, A., Ajilore, O., Hsieh, J., Ho, D., Lawrence, M., McGaugh, J. L., and Sapolsky, R. 2000. Sparing of neuronal function postseizure with gene therapy. Proceedings of the National Academy of Sciences of the United States of America 97: 12804-12809.
50. Meier, T. J., Ho, D. Y., and Sapolsky, R. M. 1997. Increased expression of calbindin D28k via herpes simplex virus amplicon vector decreases calcium ion mobilization and enhances neuronal survival after hypoglycemic challenge. Journal of Neurochemistry 69: 1039-1047.
51. Mueller, L. D., Rauser, C. L., and Rose, M. R. 2007. An evolutionary heterogeneity model of late-life fecundity in Drosophila. Biogerontology 8: 147-161.
52. Mumper, R. J., Wang, J., Claspell, J. M., and Rolland, A. P. 1995. Novel polymeric condensing carriers for gene delivery. Proceedings of the International Symposium on Controlled Release Bioactive Materials 22: 178-179.
53. Parsons, P. A. 2007. The ecological stress theory of aging and hormesis: An energetic evolutionary model. Biogerontology 8: 233-242.
54. Pearson, S., Jia, H., and Kandachi, K. 2004. China approves first gene therapy. Nature Biotechnology 22: 3-4.
55. Petersen, H., Fechner, P. M., Martin, A. L., Kunath, K., Stolnik, S., Roberts, C. J., Fischer, D., Davies, M. C., and Kissel, T. 2002. Polyethylenimine-graft-poly (ethylene glycol) copolymers: Influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chemistry 13: 845-854.
56. Qi, X., Sun, L., Lewin, A. S., Hauswirth, W. W., and Guy, J. 2007. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: Antioxidant gene therapy. Investigative Ophthalmology & Visual Science 48: 5360-5370.
57. Rattan, S. I. 2007. The science of healthy aging: Genes, milieu, and chance. Annals of the New York Academy of Sciences 1114: 1-10.
58. Roldo, M., Hornof, M., Caliceti, P., and Bernkop-Schnurch, A. 2004. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: Synthesis and in vitro evaluation. European Journal of Pharmaceutics and Biopharmaceutics 57: 115-121.
59. Shi, G., Guo, W., Stephenson, S. M., and Lee, R. J. 2002. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. Journal of Controlled Release 80: 309-319.
60. Simonato, M., Manservigi, R., Marconi, P., and Glorioso, J. 2000. Gene transfer into neurones for the molecular analysis of behaviour: Focus on herpes simplex vectors. Trends in Neurosciences 23: 183-190.
61. Sun, J. Y., Anand-Jawa, V., Chatterjee, S., and Wong, K. K. 2003. Immune responses to adeno-associated virus and its recombinant vectors. Gene Therapy 10: 964-976.
62. Sun, S., Liu, W., Cheng, N., Zhang, B., Cao, Z., Yao, K., Liang, D., Zuo, A., Guo, G., and Zhang, J. 2005. A thermoresponsive chitosan-NIPAAm/vinyl laurate copolymer vector for gene transfection. Bioconjugate Chemistry 16: 972-980.
63. Swami, A., Aggarwal, A., Pathak, A., Patnaik, S., Kumar, P., Singh, Y., and Gupta, K. C. 2007a. Imidazolyl-PEI modified nanoparticles for enhanced gene delivery. International Journal of Pharmaceutics 335: 180-192.
64. Swami, A., Kurupati, R. K., Pathak, A., Singh, Y., Kumar, P., and Gupta, K. C. 2007b. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochemical and Biophysical Research Communications 362: 835-841.
65. Thanou, M., Florea, B. I., Geldof, M., Junginger, H. E., and Borchard, G. 2002. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 23: 153-159.
66. Theti, D. S. and Jackman, A. L. 2004. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs. Clinical Cancer Research 10: 1080-1089.
67. Tomlinson, B. E. 1976. Some quantitative cerebral findings in normal and demented old people. In Neurobiology of Aging, eds. R. D. Terry and S. Gershon, pp. 183-227. New York: Raven Press.
68. von Harpe, A., Petersen, H., Li, Y., and Kissel, T. 2000. Characterization of commercially available and synthesized polyethylenimines for gene delivery. Journal of Controlled Release 69: 309-322.
69. Wong, K., Sun, G., Zhang, X., Dai, H., Liu, Y., He, C., and Leong, K. W. 2006. PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjugate Chemistry 17: 152-158.
70. Yilmaz, M., Ozsoy, E. D., and Bozcuk, A. N. 2008. Maternal age effects on longevity in Drosophila melanogaster populations of different origin. Biogerontology 9: 163-168.
71. Zhang, L., Li, L., Hoffmann, G. A., and Hoffman, R. M. 1996. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: An approach to gene therapy of skin aging and other diseases. Biochemical and Biophysical Research Communications 220: 633-636.
72. Zhu, S. and Li, S. 2008. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation. Methods in Molecular Biology 423: 327-337.
73. Zou, S. M., Erbacher, P., Remy, J. S., and Behr, J. P. 2000. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. The Journal of Gene Medicine 2: 128-134.